INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

COLLEGIUM PHARMACEUTICAL, INC

Filed

November 14, 2024

Period of Report

November 12, 2024

Accession Number

0001062993-24-019164